These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1828548)

  • 1. Effects of sex steroids on skin 5 alpha-reductase activity in vitro.
    Cassidenti DL; Paulson RJ; Serafini P; Stanczyk FZ; Lobo RA
    Obstet Gynecol; 1991 Jul; 78(1):103-7. PubMed ID: 1828548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Receptivity to the sex steroids, physiopathological aspects].
    Bercovici JP
    Contracept Fertil Sex (Paris); 1984 Jun; 12(6):821-7. PubMed ID: 12313177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M; Carol W; Gräser T; Klinger G; Mellinger U; Moore C; Schindler AE; Winkler UH
    Zentralbl Gynakol; 1997; 119(12):597-606. PubMed ID: 9483810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormones and the fertilizing capacity of spermatozoa.
    Briggs MH
    Steroids; 1973 Oct; 22(4):547-53. PubMed ID: 4127001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of rat liver delta 4-3-ketosteroid-5 alpha-reductase by steroids in vitro].
    Schubert K; Schumann G; Rose G; Ritter F; Strecke J; Schlegel J
    Endokrinologie; 1978 May; 72(2):141-8. PubMed ID: 738209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of skin 5 alpha-reductase by oral contraceptive progestins in vitro.
    Rabe T; Kowald A; Ortmann J; Rehberger-Schneider S
    Gynecol Endocrinol; 2000 Aug; 14(4):223-30. PubMed ID: 11075290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the potency of orally administered progestins in women.
    King RJ; Whitehead MI
    Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of progesterone and synthetic progestins on serum- and estradiol-stimulated proliferation of human breast cancer cells.
    Seeger H; Wallwiener D; Mueck AO
    Horm Metab Res; 2003 Feb; 35(2):76-80. PubMed ID: 12734785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal rings for contraception: endocrine parameters.
    Olsson SE
    Adv Contracept Deliv Syst; 1992; 8(1-2):71-3. PubMed ID: 12285565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
    Levin JH; Tonetta SA; Lobo RA
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1932-8. PubMed ID: 2147816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 19. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.